Page last updated: 2024-09-03

delta-philanthotoxin and muromonab-cd3

delta-philanthotoxin has been researched along with muromonab-cd3 in 1 studies

Compound Research Comparison

Studies
(delta-philanthotoxin)
Trials
(delta-philanthotoxin)
Recent Studies (post-2010)
(delta-philanthotoxin)
Studies
(muromonab-cd3)
Trials
(muromonab-cd3)
Recent Studies (post-2010) (muromonab-cd3)
6301185150

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hablitz, JJ; Mathew, SS1

Other Studies

1 other study(ies) available for delta-philanthotoxin and muromonab-cd3

ArticleYear
Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex.
    Neuropharmacology, 2008, Volume: 55, Issue:1

    Topics: Animals; Boron Compounds; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Inositol 1,4,5-Trisphosphate Receptors; Kainic Acid; Macrocyclic Compounds; Neocortex; Neurons; Nicotinic Antagonists; Oxazoles; Patch-Clamp Techniques; Polyamines; Presynaptic Terminals; Rats

2008